Here’s how defender Francesco, 37, has risen from Italy’s 4th division, battled depression, alcoholism and survived cancer ...

Francesco Acerbi, a player for Inter Milan, is synonymous with grit, determination, and inspiration; he beat cancer and is ...

Early in his career, Francesco Acerbi overcame alcoholism, depression and cancer twice. Now, at 37, he is Champions League ...

Charlie Pepe went 4-for-4 with three RBI and two runs to lead second-seeded Verona past 15th-seeded McNair 17-2 in the North Jersey, Section 2, Group 1 first round in Verona. Connor Zimany ...

Police say they are still looking for the fourth suspect in a Verona shooting that happened in March. Police are asking the public for assistance in finding a fourth suspect involved in a shooting ...

In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against other stocks that Jim Cramer discusses. Answering a caller’s query about Verona Pharma plc ...

Verona added four more runs in the second inning and five in the third before Secaucus scored all five of its runs in the fourth inning. Synclaire Szamborski matched McClellan with four RBIs while ...

Hellas Verona defender Diego Coppola received his first senior Italy call-up and is now reportedly in talks for a Premier League move to Brighton and Hove Albion or Aston Villa. Coppola was named ...

After a loan spell at Renate in Serie D, Acerbi began touring Italy with moves to Reggina, Genoa and Chievo, where he made his Serie A debut and emerged as one of the most promising defenders in ...

Track and field athletes gathered at Vernon Verona Sherrill High School on Thursday for the Section III Class B-1 championship meet. The VVS girls’ squad won the title with 142.5 points ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster. The first-in-class dual ...